Immediate Impact
2 from Science/Nature 56 standout
Citing Papers
Why do patients with cancer die?
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Works of Rita Secola being referenced
A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report
2009
Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rita Secola | 104 | 88 | 36 | 95 | 23 | 323 | |
| Maureen Haugen | 83 | 92 | 12 | 53 | 13 | 294 | |
| Jessica M. Valdez | 101 | 54 | 25 | 61 | 15 | 358 | |
| Zvonimir Puretić | 41 | 39 | 58 | 58 | 22 | 368 | |
| Sanna‐Maria Kivivuori | 48 | 25 | 50 | 32 | 20 | 253 | |
| Evan Shereck | 54 | 105 | 10 | 55 | 24 | 296 | |
| Joanne Bayly | 57 | 82 | 13 | 77 | 28 | 314 | |
| Jochen Roessler | 37 | 36 | 40 | 18 | 21 | 293 | |
| Meike Ressing | 44 | 70 | 6 | 95 | 15 | 357 | |
| Deborah Parks | 35 | 27 | 47 | 23 | 17 | 357 | |
| Ruta Tuckuviene | 93 | 214 | 54 | 90 | 26 | 367 |
All Works
Login with ORCID to disown or claim papers
Loading papers...